A new technology, Sync AR, is giving surgeons x-ray vision by fusing digitally enhanced images directly into the microscope of a surgical device. The devices use augmented reality to make it easy for surgeons to perform complex surgeries.
It is a partnership between Los Angeles-based health tech innovators Surgical Theater, an Irish medical device company Medtronic.
This system enables access to all the information in one place. While surgeons actually need to gaze toward the separate screen to get to patient information or improved visuals.
It was designed specifically for complex neurosurgeries and includes augmented reality,3D images, that are made utilizing Surgical Theater’s SyncAR technology. Each picture shows an itemized visual of the particular body part that is being operated on, built using a patient’s anatomical scans, for example, an MRI or a CT scan.
These SyncAR images are embedded directly into a Medtronic’s StealthStation S8 surgical device – a navigation framework that is fitted with both a microscope and a screen. The images are complete with color markings and precise 3D visuals of arteries, vessels, nerves and more.
The surgeon then utilizes this innovation to move to and fro between real human biological tissue and the augmented scan, which serves just like a guide: highlighting crucial areas of a patient’s anatomy so a surgeon can think about the most proficient way to focus on a trouble spot, such as a brain tumor, and visualize its surroundings.
Avisar, CEO of Surgical Theatre, says the technology is already showing valuable applications. In the case of tumor removal, he says the technology permits the specialist to coordinate the most proficient pathway, yet in addition to seeing past the tumor itself by allowing them to see the dark side of the tumor, they’re able to spot key nerves and vessels on the other side and avoid them.
He says, The technology has been FDA approved in the US and is right now being tested by surgeons there, with plans to expand to hospitals in Europe before the year’s over.